by Don McLean | Oct 27, 2020 | Blog
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines by Samantha Hoopes, PhD, RAC The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on Thursday, October 22,...
by Don McLean | Jul 10, 2020 | Blog
Why COVID-19 testing devices require a high level of specificity by Patrick Hannon, PhD, Japie Lowings, and Aditya Gadiko Note: To use the dashboard, read the article below, then click the arrows on the dashboard to enter full screen mode. Use the dashboard to find...
by Don McLean | Jun 11, 2020 | News
Helping to Accelerate the Search for Solutions to the COVID-19 Crisis By Rob DiCicco – Deputy Chief Health Officer, IBM Watson Health, June 11, 2020 The full article can be read on the IBM Watson Health website. An excerpt of the article is below. The novel...
by Don McLean | Jun 9, 2020 | News
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment THUNDER BAY, ONTARIO (June 09, 2020) — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the...
by Don McLean | May 29, 2020 | Blog
Pharmaceutical Industry News Roundup: May 2020 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from May: Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World...
